US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.37

-0.0500-0.15%

Post-market: 34.370.00000.00%19:30 EDT

Volume:134.91K

Turnover:4.64M

Market Cap:105.52M

PE:- -

High:34.78

Open:34.78

Low:34.20

Close:34.42

52wk High:36.84

52wk Low:25.00

Shares:3.07M

Float Shares:3.07M

Volume Ratio:2.41

T/O Rate:4.39%

Dividend:0.39

Dividend Rate:1.14%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Moderna Inc. Stock Advances 7.0%, Outperforms Peers

Regeneron to Report Q3 Results, Host Conference Call and Webcast

Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026

Regeneron Approaching Incremental Catalysts Like Upcoming Olatorepatide Data Readout, RBC Says

MT Newswires Live

CSPC Pharma's JMT101 Combined with Osimertinib Achieves Positive Topline Results in Phase III Trial for First-Line Treatment of EGFR ex20ins NSCLC

Sino Biopharmaceutical Stock Slips 1.8% in Hong Kong

Hong Kong Market Flash: BOAN BIOTECH Jumps Over 8% in Late Session as BA1203 Gets Clinical Trial Nod from NMPA

Leerink Partners Remains a Hold on Amgen (AMGN)

Innocare Pharma Forges Collaboration with Eli Lilly, Unlocking Potential Milestone Payments of Up to $3.25 Billion

US Judge Steps Aside in Dispute over Hawaii Energy Settlement

Stoke Therapeutics Names Solid Biosciences CEO Bo Cumbo to Board

Amgen Stock Forecast: AMGN Reclaims $410 as Pipeline Catalysts Build

Kaisa Health Rebrands as Qinghai Biotech Pharmaceutical on Stock Exchange

Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nektar Therapeutics (NKTR)

Boyayuan Evidence-Based China Tour: Real-World Pharmacoeconomics Symposium Successfully Concludes in Shenzhen (South China Session)

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX)

ETF Market Update (09.23): Oil Geopolitical Premium Fades on Supply Resumption and Diplomatic Thaw, While Innovative Drugs Rally Against the Trend

Jiangsu Hengrui Pharmaceuticals Secures Clinical Trial Approvals for Ten Drug Candidates

Guangdong Taienkang Pharmaceutical's Subsidiary Reports Positive Phase IIa Interim Findings for CKBA Cream in Rosacea Treatment

Innovative Drug Sector Surges Again on Multiple Tailwinds; On-Site Hot Targets 520880 and 159137 Defy Market Downturn

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/IBBQ/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.37,"timestamp":1790971200000,"preClose":34.42,"halted":0,"volume":134914,"hourTrading":{"tag":"盘后","latestPrice":34.37,"preClose":34.37,"latestTime":"19:30 EDT","volume":23,"amount":793.71,"timestamp":1790983804820,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0014526438117374858,"floatShares":3070000,"shares":3070000,"eps":0,"marketStatus":"Market Closed","change":-0.05,"latestTime":"10-02 16:00:00 EDT","open":34.78,"high":34.78,"low":34.2,"amount":4640242.504378,"amplitude":0.016851,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":34.42,"sharesOutstanding":2520001,"nav":34.4248,"aum":106440372.14,"dividendRate":0.01135,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":34.5,"preClose":34.42,"latestTime":"07:58 EDT","volume":100,"amount":3450,"timestamp":1790942314618,"change":0.08,"changeRate":0.002324,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":34.37,"preClose":34.37,"latestTime":"19:30 EDT","volume":23,"amount":793.71,"timestamp":1790983804820,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.412124809157592,"impliedVol":0.1226,"impliedVolPercentile":0.5299},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":3070000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.412124809157592,"shares":3070000,"dividePrice":0.3901,"high":34.78,"amplitude":0.016851,"preClose":34.42,"low":34.2,"week52Low":25,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.37,"eps":0,"divideRate":0.01135,"volume":134914,"delay":0,"ttmEps":0,"open":34.78,"prevYearClose":28.3962,"prevWeekClose":35,"prevMonthClose":35.14,"prevQuarterClose":35.14,"fiveDayClose":35,"twentyDayClose":36.26,"sixtyDayClose":33.97},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"IBBQ","amount":0.23037,"announcedDate":"2026-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670184794","title":"Moderna Inc. Stock Advances 7.0%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2670184794","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670184794?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:33","pubTimestamp":1790281980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rose 7.0% to $194.82 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index remaining mostly unchanged at 26,939.37 and the Dow Jones Industrial Average falling 0.3% to 51,349.98.Moderna Inc. hit a new 52-week high, surpassing its previous peak of $192.31, which the company reached on September 23rd.The stock outperformed some of its peers, as Johnson & Johnson rose 0.6% to $270.68, Pfizer Inc. rose 0.8% to $28.41, and Gilead Sciences Inc. fell 1.11% to $149.69.Trading volume totaled 16.4 million, compared to the 50-day average of 18.6 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509101.SGD","LU1674673428.USD","TBXU","LU1778281490.HKD","IE00BZ1G4Q59.USD","LU2468319806.SGD","IE00B19Z3B42.SGD","IBB","MRNY","LU2324357040.USD","LU0234570918.USD","LU0289739699.SGD","LU2112291526.USD","LGHT","WDNA","BBH","GNOM","SG9999015952.SGD","LU0965508806.USD","LU0965509010.AUD","IE00B3T34201.USD","BK4550","IE00BKVL7J92.USD","BK4534","BK4551","MRNX","BK4568","BMED","IE00B19Z3581.USD","LU1430594728.SGD","IE0002270589.USD","LU1571399168.USD","IBBQ","LU0861579265.USD","LU0965509283.SGD","LU1066053197.SGD","LU1057294990.SGD","LU1061106388.HKD","BK4532","LU2357627491.SGD","LU1934455863.HKD","MEDI","LU0859254822.USD","TMED","BIB","BK4533","IDNA","MRNA","GILD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670541882","title":"Regeneron to Report Q3 Results, Host Conference Call and Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2670541882","media":"Reuters","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670541882?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:06","pubTimestamp":1790280375,"startTime":"0","endTime":"0","summary":"Regeneron to report Q3 results, host conference call and webcastRegeneron schedules third-quarter 2026 financial results for Oct. 30, 2026, before the U.S. market open.Conference call, webcast set for","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL85Bt96:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU2362541273.HKD","IE00BGHQF748.EUR","LU0882574055.USD","LU0823434583.USD","IE00B64PRP62.GBP","LU0320765992.SGD","LU2095319765.USD","LU0114720955.EUR","LU2089984988.USD","IE00BQXX3C00.GBP","BBH","LU2023250504.SGD","IE00BKPKM429.USD","IE00BN0W2V16.EUR","IBB","BK4585","LU1974910355.USD","IE00BQXX3D17.EUR","BCDF","LU0058720904.USD","LU0823416689.USD","SG9999014039.USD","BK4588","LU0289739699.SGD","SG9999014005.SGD","LU1917777945.USD","LU2362541513.USD","LU0109394709.USD","LU2362540622.SGD","BK4112","BK4139","LU2468319806.SGD","NDAQ","SG9999014013.SGD","LU0314104364.USD","LU0823434740.USD","REGN","IE00BN0W2W23.USD","SG9999014021.USD","LU2210149790.SGD","IE00BQXX3F31.USD","TBXU","IBBQ","LU0053666078.USD","LU2106854487.HKD","LU2237438978.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670183654","title":"Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2670183654","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670183654?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:05","pubTimestamp":1790280300,"startTime":"0","endTime":"0","summary":"TARRYTOWN, N.Y., Sept.  24, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its third quarter 2026 financial and operating results on Friday","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/24/3368733/0/en/regeneron-to-report-third-quarter-2026-financial-and-operating-results-and-host-conference-call-and-webcast-on-october-30-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","IBB","LU2362540622.SGD","LU0109394709.USD","LU0053666078.USD","LU0320765992.SGD","REGN","LU2362541513.USD","LU1917777945.USD","LU2237438978.USD","TBXU","LU0889565916.HKD","LU2023250504.SGD","LU2468319806.SGD","BK4585","LU2106854487.HKD","BK4139","LU0882574055.USD","LU0823434740.USD","LU1974910355.USD","LU0058720904.USD","LU0114720955.EUR","BBH","BK4588","LU0823434583.USD","LU0289739699.SGD","LU2089984988.USD","IBBQ","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669043491","title":"Regeneron Approaching Incremental Catalysts Like Upcoming Olatorepatide Data Readout, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2669043491","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669043491?lang=en_us&edition=fundamental","pubTime":"2026-09-24 23:29","pubTimestamp":1790263782,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals  is approaching a series of incremental catalysts, including the data readout from the phase 3 China study of olatorepatide next week, RBC Capital Markets said in a Thursday note.RBC said topline efficacy data on olatorepatide, the company's weight-management product candidate, has been generally announced, with up to a 19% mean weight loss at week 48. Focus would be on the safety of therapy at the 15-milligram dose, the brokerage noted.Late-breaking abstract data indicate the 15-milligram dose as the best option to proceed with, versus other evaluated doses, based on efficacy, though safety details remain pending, RBC said. Olatorepatide's initial safety profile seem \"more benign\" compared with tirzepatide, but the China data could bring more reassurance to investors, the investment firm added.RBC maintained its sector perform rating on Regeneron Pharmaceuticals, with a $737 price target.Price: 799.53, Change: -2.29, Percent Change: -0.29","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0889565916.HKD","LU2468319806.SGD","REGN","BBH","LU2023250504.SGD","LU0320765992.SGD","LU2237438978.USD","BK4585","LU0823416689.USD","LU1974910355.USD","IBB","LU0289739699.SGD","IBBQ","TBXU","LU2362540622.SGD","LU2089984988.USD","LU0053666078.USD","LU0058720904.USD","LU2362541273.HKD","LU0823434583.USD","LU0109394709.USD","LU2362541513.USD","BK4588","LU0823434740.USD","LU1917777945.USD","LU2106854487.HKD","BK4139","LU0882574055.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183769643","title":"CSPC Pharma's JMT101 Combined with Osimertinib Achieves Positive Topline Results in Phase III Trial for First-Line Treatment of EGFR ex20ins NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=1183769643","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183769643?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:28","pubTimestamp":1790252894,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that the Phase III clinical trial of its developed becotatug (JMT101) in combination with osimertinib for the first-line treatment of locally advanced or metastatic...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","LU1008478684.HKD","IBBQ","LU1152091168.USD","MDTX","LU0314109678.HKD","HK0000165453.HKD","LU0315179316.USD","BK1515","SG9999004220.SGD","LU0140636845.USD","IBBJ","LU0067412154.USD","IE0008368742.USD","LU1226287792.SGD","LU1226288253.USD","LU0880133367.SGD","LU1807302812.USD","BMED","BK1191","LU1152091754.HKD","01093","PSYK","LU1226287875.USD","IE00BZ08YR35.GBP","KURE","LU0072913022.USD","LU1813983027.USD","LU1993786604.SGD","IE0008369823.USD","IE00B5MMRT66.SGD","IE00BZ08YT58.USD","LU1226288170.HKD","IE00BZ08YS42.EUR","BK1521","LU0501845795.SGD","LU1226287529.USD","LU2039709279.SGD","IE00B543WZ88.USD","LU1328277881.USD","LU1951186391.HKD","IE00B031HY20.USD","LU1960683339.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669463318","title":"Sino Biopharmaceutical Stock Slips 1.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2669463318","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669463318?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:31","pubTimestamp":1790238660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 1.8% to 5.59 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.3% to 24761.13.This was the stock's third consecutive day of losses.Sino Biopharmaceutical Ltd. closed 35% below its 52-week high of HK$8.54, which the company reached Oct. 8.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 3.2% and Amgen Inc. remained unchanged.Trading volume totaled 52.8 million shares, compared to the 50-day average of 85.9 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","LU1983299246.USD","LU2468319806.SGD","BK4585","BK1515","BK4599","BK1589","IBB","BIB","PBE","LU2112291526.USD","AMGN","BK4566","PJP","LU0320765992.SGD","BK4581","IE00B4R5TH58.HKD","HK0000165453.HKD","LU1061106388.HKD","BK1191","LU0889565916.HKD","IE00BZ08YT58.USD","LU2089984988.USD","IE0002141913.USD","IE00BZ08YS42.EUR","IE0009355771.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0058720904.USD","BK4534","BK4588","LU0868494617.USD","LU1023059063.AUD","LU0122379950.USD","TBXU","BBH","LU0109394709.USD","LU0289739699.SGD","BK4533","IE00BJJMRZ35.SGD","01177","SG9999001440.SGD","LU1571399168.USD","LU1057294990.SGD","BK4139","LU2242652126.USD","IE00BFTCPJ56.SGD","BK1521","IE00BZ08YR35.GBP","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178729397","title":"Hong Kong Market Flash: BOAN BIOTECH Jumps Over 8% in Late Session as BA1203 Gets Clinical Trial Nod from NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1178729397","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178729397?lang=en_us&edition=fundamental","pubTime":"2026-09-24 15:46","pubTimestamp":1790235998,"startTime":"0","endTime":"0","summary":"Shares of BOAN BIOTECH (06955) climbed more than 8% in late trading, with the stock last up 7.66% at HK$2.95, recording turnover of approximately HK$2.94 million.The move comes after the company...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","06955","MDTX","PSYK","BK4585","IBBJ","BK4588","BK1161","VXUS","KCAI","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669381451","title":"Leerink Partners Remains a Hold on Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669381451","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669381451?lang=en_us&edition=fundamental","pubTime":"2026-09-24 13:15","pubTimestamp":1790226924,"startTime":"0","endTime":"0","summary":"In a report released yesterday, from Leerink Partners maintained a Hold rating on Amgen. The company’s shares closed yesterday at $406.09. In addit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/leerink-partners-remains-a-hold-on-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/leerink-partners-remains-a-hold-on-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","LU2242646821.SGD","IE00BFTCPJ56.SGD","BK4599","LU2242652126.USD","LU2468319806.SGD","SG9999001440.SGD","LU2112291526.USD","BIB","BBH","LU1023059063.AUD","BK4585","PBE","LU1983299246.USD","BK4139","PJP","AMGN","LU0889565916.HKD","LU1571399168.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","IE0009355771.USD","IE00B2B36J28.USD","IE0002141913.USD","TBXU","IBB","IE00B4R5TH58.HKD","IBBQ","BK4581","LU1061106388.HKD","LU0122379950.USD","LU0320765992.SGD","BK4533","BK4534","BK4588","LU0289739699.SGD","LU2089984988.USD","IE00BJJMRZ35.SGD","LU0868494617.USD","LU0058720904.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130888922","title":"Innocare Pharma Forges Collaboration with Eli Lilly, Unlocking Potential Milestone Payments of Up to $3.25 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1130888922","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130888922?lang=en_us&edition=fundamental","pubTime":"2026-09-24 12:16","pubTimestamp":1790223378,"startTime":"0","endTime":"0","summary":"Innocare Pharma Limited (688428.SH) has announced that its wholly-owned subsidiary, Beijing InnoCare Pharma Tech Co., Ltd., has entered into a research collaboration and exclusive license agreement...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","06978","IBBQ","688428","MEDX","09969","BK0239","159992","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669843952","title":"US Judge Steps Aside in Dispute over Hawaii Energy Settlement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669843952","media":"Reuters","labels":["policyRegulatory","event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669843952?lang=en_us&edition=fundamental","pubTime":"2026-09-24 05:00","pubTimestamp":1790197259,"startTime":"0","endTime":"0","summary":"US judge steps aside in dispute over Hawaii energy settlementSept 23 (Reuters)-A federal judge in Hawaii has disqualified himself from hearing a dispute over whether a decades-old price-fixing settlem","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL6N45F14Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEXU","TRUN","LU0234570918.USD","LU2468319806.SGD","BK4201","BBH","LU0098860793.USD","MEDI","LU0122376428.USD","TMED","LU2129689605.HKD","LU0256863811.USD","LU0149725797.USD","IYE","BMED","IBB","LU0265550359.USD","LU0965509010.AUD","FENY","LU0265550946.USD","LU0640476718.USD","XLE","VDE","IBBQ","IGE","TBXU","DIG","IE0002270589.USD","GILD","LU0162691827.USD","LU0861579265.USD","LU1929549753.HKD","LU0300736062.USD","GXPE","FTXN","BIB","ERX","LU0456854461.SGD","SG9999002521.SGD","DRLL","BK4588","CVX","BK4559","IE00B3T34201.USD","LU0868494708.USD","WEEI","IE00B19Z3B42.SGD","IXC","LU1037948541.HKD","LU0942090050.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669090435","title":"Stoke Therapeutics Names Solid Biosciences CEO Bo Cumbo to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2669090435","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669090435?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:01","pubTimestamp":1790193684,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics names Solid Biosciences CEO Bo Cumbo to boardStoke Therapeutics appointed Bo Cumbo to its board.Edward Kaye retired as a director; he served on the board since 2017 and was CEO from","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL9kWWfM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","IBBQ","IE00BFTCPJ56.SGD","SLDB","IE00BJJMRZ35.SGD","LU1037948541.HKD","LU2468319806.SGD","STOK","MEDI","IE00BJT1NW94.SGD","BIB","LU2087621335.USD","LU0320765992.SGD","LU0965509101.SGD","LU0122379950.USD","BK4578","BMED","IE0009355771.USD","IE00BSNM7G36.USD","LU1674673691.USD","BK4550","LU0859254822.USD","LU1674673428.USD","SRPT","LU1778281490.HKD","TMED","LU1934455277.USD","LU0882574055.USD","IBB","TBXU","BK4585","BK4139","GILD","LU1066053197.SGD","IE0002270589.USD","IE00B19Z3581.USD","LU2112291526.USD","BK4588","LU0889565916.HKD","LU2324357040.USD","LU0109394709.USD","LU1061106388.HKD","SRPU","BBH","IE00B2B36J28.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU1934455194.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669646482","title":"Amgen Stock Forecast: AMGN Reclaims $410 as Pipeline Catalysts Build","url":"https://stock-news.laohu8.com/highlight/detail?id=2669646482","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669646482?lang=en_us&edition=fundamental","pubTime":"2026-09-23 23:00","pubTimestamp":1790175600,"startTime":"0","endTime":"0","summary":"Amgen rebounds to $410.24 as dazodalibep and IMDELLTRA strengthen the pipeline while $418.73 becomes the next technical test.\n","market":"hk","thumbnail":"https://resource.tradingkey.com/uploads/20260923/AMGEN-82b57eea98fd4d6fa458e68c35b3ab95.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260923/AMGEN-82b57eea98fd4d6fa458e68c35b3ab95.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262182585-stocks-amgen-stock-forecast-pipeline-410-breakout-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","LU2237443549.SGD","TSLR","TSLQ","TSLG","TSLT","PBE","TSL","07766","AZNH","TSLO","TSLL","BGSX","ORR.AU","BBH","TSLZ","TSLS","07366","IE0009355771.USD","LU2242652126.USD","TBXU","TEST","BIB","AZN","TSYY","LU2468319806.SGD","TSDD","IBB","AMGN","PFS","TSLI","LU1983299246.USD","TSLP","ELOL","PJP","LU0868494617.USD","TSII","IBBQ","09366","TESC","09766","CRSH","IE0002141913.USD","TSLY","TLA","ORR","TESL","LU1571399168.USD","LU1061106388.HKD","TSLW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188760602","title":"Kaisa Health Rebrands as Qinghai Biotech Pharmaceutical on Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=1188760602","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188760602?lang=en_us&edition=fundamental","pubTime":"2026-09-23 22:46","pubTimestamp":1790174774,"startTime":"0","endTime":"0","summary":"Kaisa Health (00876) has announced a corporate identity overhaul, with its official English name transitioning from \"Kaisa Health Group Holdings Limited\" to \"Qinghai Biotech Pharmaceutical Group...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03069","BK1222","MRNY","02954","BK1121","BK1239","MRNX","BK1230","00876","BBP","BK1154","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669648508","title":"Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nektar Therapeutics (NKTR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669648508","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669648508?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:30","pubTimestamp":1790166641,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nek...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kymera-therapeutics-kymr-vertex-pharmaceuticals-vrtx-and-nektar-therapeutics-nktr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kymera-therapeutics-kymr-vertex-pharmaceuticals-vrtx-and-nektar-therapeutics-nktr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z3581.USD","BK4139","LU0757428866.USD","LU2417539215.USD","VERX","LU0289739699.SGD","LU1559883803.SGD","SG9999001176.SGD","LABU","BBH","LU0109394709.USD","NKTR","IE0002270589.USD","VRTX","BK4585","XBI","GNMX","XLV","IBB","LU2362541513.USD","LU0256863811.USD","BIB","LU0234570918.USD","SG9999001176.USD","BK4533","LU0823416689.USD","TBXU","IBBQ","LU0061475181.USD","IDNA","LU2237438978.USD","LU0417517546.SGD","IE0002141913.USD","KYMR","LU0432979614.USD","BK4007","LU1674673428.USD","IE00BZ9MQY76.HKD","LU2324357040.USD","HCSG","LU2089984988.USD","LU2362541273.HKD","PBE","BK4023","IE00BJJMRZ35.SGD","LU1035775433.USD","LU1069344957.HKD","IE00B19Z3B42.SGD","IE00B894F039.SGD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124603429","title":"Boyayuan Evidence-Based China Tour: Real-World Pharmacoeconomics Symposium Successfully Concludes in Shenzhen (South China Session)","url":"https://stock-news.laohu8.com/highlight/detail?id=1124603429","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124603429?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:51","pubTimestamp":1790157060,"startTime":"0","endTime":"0","summary":"On September 22, the fourth stop of the national roadshow series, the South China special session on \"Real-World Pharmacoeconomics Research,\" was successfully held at the Conference Center of...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RCT","IBBQ","BK4159","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669711101","title":"Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669711101","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669711101?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:10","pubTimestamp":1790154626,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Quest Diagnostics (DGX), AnaptysBio (ANAB) and Verte...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quest-diagnostics-dgx-anaptysbio-anab-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quest-diagnostics-dgx-anaptysbio-anab-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","IE00B19Z3B42.SGD","LABU","IE00BZ9MQY76.HKD","BBH","IBBQ","IE00B2B36J28.USD","PBE","VRTX","XLV","LU2506952170.USD","BK4139","FFTY","IE00BJJMRZ35.SGD","LU2456880835.USD","LU0823417737.USD","IBB","LU2462157665.USD","TBXU","IE0002270589.USD","SG9999001176.SGD","BK4567","LU0823417653.USD","SGXZ57979304.SGD","LU1854103824.USD","XBI","IE0009355771.USD","BIB","VERX","LU2506952097.USD","LU1585245621.USD","LU0823416689.USD","LU0234570918.USD","GNMX","ANAB","LU1035775433.USD","BK4583","LU2089984988.USD","LU0289739699.SGD","HCSG","LU0757428866.USD","LU0079474960.USD","LU1815336091.USD","DGX","IDNA","IE00BJT1NW94.SGD","SG9999001176.USD","LU2506951875.HKD","LU1093756325.SGD","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160389974","title":"ETF Market Update (09.23): Oil Geopolitical Premium Fades on Supply Resumption and Diplomatic Thaw, While Innovative Drugs Rally Against the Trend","url":"https://stock-news.laohu8.com/highlight/detail?id=1160389974","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160389974?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:58","pubTimestamp":1790153909,"startTime":"0","endTime":"0","summary":"Hong Kong's three major indices weakened collectively on Monday, with tech stocks broadly under pressure and only a few sectors such as mainland property and pharmaceutical biotech managing to rise...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","DBC","XES","ERX","BZmain","DBE","DBO","CLmain","USO","FBZ","MEDX","FTXN","WTIU","IXC","MCLmain","BNO","BK4570","BK1161","IEO","DWT","OILU","VDE","XOP","BK1574","FAAR","UCO","DUG","159992","FDN","DDG","DRIP","USL","OILT","SCO","USE","OIH","PXJ","DIG","QMmain","BK4550","BK4588","UGA","DRLL","FLBR","PXE","OILK","USOI","06978","LNGR","GUSH","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112810908","title":"Jiangsu Hengrui Pharmaceuticals Secures Clinical Trial Approvals for Ten Drug Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=1112810908","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112810908?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:42","pubTimestamp":1790152956,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (600276.SH) has announced that it and its subsidiaries recently received Drug Clinical Trial Approval Notices from the National Medical Products...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828557.USD","LU0359201612.USD","BK1191","LU1655091616.SGD","LU1997245177.USD","LU2495084118.USD","LU2097828474.EUR","BK0196","LU1146622755.USD","LU1328615791.USD","LU1820825898.SGD","LU2148510915.USD","LU0405327494.USD","LU1997245094.SGD","LU2328871848.SGD","PSYK","LU2289578879.USD","LU1064130708.USD","LU2543165471.USD","LU2097828714.EUR","LU1969619763.USD","MDTX","BK0183","LU2580892862.HKD","BMED","LU2488822045.USD","LU1064131003.USD","LU2580892789.USD","01276","BK0028","LU0405327148.USD","LU1255011170.USD","LU1023057109.AUD","BK0239","BK0188","BK0060","LU0359201885.HKD","LU1997244956.HKD","LU1781817850.SGD","IBBJ","LU2097828631.EUR","LU1580142542.USD","IBBQ","BK0012","LU0359202008.SGD","600276","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132076629","title":"Guangdong Taienkang Pharmaceutical's Subsidiary Reports Positive Phase IIa Interim Findings for CKBA Cream in Rosacea Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1132076629","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132076629?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:16","pubTimestamp":1790151378,"startTime":"0","endTime":"0","summary":"Guangdong Taienkang Pharmaceutical Co., Ltd. (301263.SZ) has announced that its controlled subsidiary, Jiangsu Bochuangyuan Biomedical Technology Co., Ltd., has completed data collection for its...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0250","IBBJ","PSYK","BMED","301263","IBBQ","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182951302","title":"Innovative Drug Sector Surges Again on Multiple Tailwinds; On-Site Hot Targets 520880 and 159137 Defy Market Downturn","url":"https://stock-news.laohu8.com/highlight/detail?id=1182951302","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182951302?lang=en_us&edition=fundamental","pubTime":"2026-09-23 14:41","pubTimestamp":1790145669,"startTime":"0","endTime":"0","summary":"On September 23, Hong Kong's pharmaceutical sector resumed its upward momentum after a day of consolidation. Innovative drug development companies saw broad gains, with Immunotech-B leading the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LNGR","520880","MEDX","BK1161","06978","BK1574","159992","159137"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}